Pablo Sarobe

7.2k total citations · 3 hit papers
125 papers, 5.5k citations indexed

About

Pablo Sarobe is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Pablo Sarobe has authored 125 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Immunology, 46 papers in Molecular Biology and 37 papers in Oncology. Recurrent topics in Pablo Sarobe's work include Immunotherapy and Immune Responses (54 papers), Immune Cell Function and Interaction (28 papers) and Hepatitis C virus research (26 papers). Pablo Sarobe is often cited by papers focused on Immunotherapy and Immune Responses (54 papers), Immune Cell Function and Interaction (28 papers) and Hepatitis C virus research (26 papers). Pablo Sarobe collaborates with scholars based in Spain, United States and France. Pablo Sarobe's co-authors include Juan José Lasarte, Ignacio Melero, Bruno Sangro, Jesús Prìeto, Sandra Hervás‐Stubbs, Francisco Borrás‐Cuesta, José Ignacio Riezu‐Boj, Noëlia Casares, Diana Llópiz and Esther Larrea and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Pablo Sarobe

122 papers receiving 5.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances in immunotherapy for hepatocellular carcinoma

2021 871 citations Bruno Sangro, Pablo Sarobe et al. Nature Reviews Gastroenterology & Hepatology profile →
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C

2013 764 citations Bruno Sangro, Mercedes Iñarrairaegui et al. Journal of Hepatology profile →
Dendritic Cells in Cancer Immunology and Immunotherapy

2024 62 citations José Luis Perez‐Gracia, Javier Rodríguez et al. Cancers profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Pablo Sarobe	2.6k	2.0k	1.5k	1.5k	935	125	5.5k
Kazuhiro Kakimi	3.6k 1.4×	2.3k 1.1×	997 0.6×	804 0.5×	1.2k 1.3×	160	5.6k
Vincenzo Barnaba	3.7k 1.4×	1.0k 0.5×	1.2k 0.8×	1.5k 1.0×	1.7k 1.8×	148	6.5k
Michael J. Brunda	3.1k 1.2×	1.6k 0.8×	1.0k 0.7×	992 0.7×	1.2k 1.2×	76	5.4k
Kevin F. Staveley-O’Carroll	2.5k 0.9×	2.1k 1.1×	1.4k 0.9×	341 0.2×	737 0.8×	124	5.0k
Ian Nicholas Crispe	4.9k 1.9×	1.3k 0.6×	1.5k 0.9×	1.7k 1.2×	1.9k 2.0×	132	8.1k
Matteo Iannacone	3.2k 1.2×	1.1k 0.5×	1.4k 0.9×	988 0.7×	1.5k 1.6×	98	6.2k
Su‐Hyung Park	1.9k 0.7×	1.2k 0.6×	818 0.5×	884 0.6×	946 1.0×	116	4.2k
Michael Geißler	818 0.3×	1.5k 0.8×	775 0.5×	755 0.5×	825 0.9×	151	3.5k
Ming Zhao	500 0.2×	1.4k 0.7×	971 0.6×	1.3k 0.9×	559 0.6×	199	6.7k
Kyogo Itoh	5.1k 1.9×	3.2k 1.6×	3.0k 1.9×	246 0.2×	618 0.7×	290	8.0k

Countries citing papers authored by Pablo Sarobe

Since Specialization

Citations

This map shows the geographic impact of Pablo Sarobe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Sarobe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Sarobe more than expected).

Fields of papers citing papers by Pablo Sarobe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Sarobe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Sarobe. The network helps show where Pablo Sarobe may publish in the future.

Co-authorship network of co-authors of Pablo Sarobe

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Sarobe. A scholar is included among the top collaborators of Pablo Sarobe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Sarobe. Pablo Sarobe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pascual, Marién, Enrique Goñi, Marı́a A. Burrell, et al.. (2025). IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy. Blood. 145(23). 2746–2761. 6 indexed citations

Fernández‐Barrena, Maite G., Iker Uriarte, Pablo Sarobe, & Matías A. Ávila. (2025). Epigenetic mechanisms in HCC immune landscape: Therapeutic implications. Seminars in Immunology. 79. 101980–101980. 1 indexed citations

Llópiz, Diana, et al.. (2025). MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinoma. OncoImmunology. 14(1). 2473165–2473165. 2 indexed citations

Senent, Yaiza, Ana Remírez, Diana Llópiz, et al.. (2024). The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response. Cancer Immunology Research. 13(3). 384–399. 6 indexed citations

Ruiz, Marta, Jorge Ruiz‐Orera, Robert Castelo, et al.. (2024). Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort. Science Advances. 10(28). eadn3628–eadn3628. 17 indexed citations

Perez‐Gracia, José Luis, Javier Rodríguez, Jaime Gállego Pérez‐Larraya, et al.. (2024). Dendritic Cells in Cancer Immunology and Immunotherapy. Cancers. 16(5). 981–981. 62 indexed citations breakdown →

Ruiz, Marta, Noëlia Casares, Leyre Silva, et al.. (2023). Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies. Frontiers in Immunology. 13. 1044025–1044025. 1 indexed citations

Sangro, Bruno, Pablo Sarobe, Sandra Hervás‐Stubbs, & Ignacio Melero. (2021). Advances in immunotherapy for hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology. 18(8). 525–543. 871 indexed citations breakdown →

Casares, Noëlia, Josune Egea, Marta Ruiz, et al.. (2021). Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses. Emerging Microbes & Infections. 10(1). 1931–1946. 13 indexed citations

10.

Salas‐Benito, Diego, Ibón Tamayo, Uxua Mancheño, et al.. (2021). The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes. British Journal of Cancer. 124(6). 1138–1149. 15 indexed citations

11.

Salas‐Benito, Diego, Teresa Lozano, Noëlia Casares, et al.. (2017). Expansion of Tumor-Infiltrating CD8+ T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy. Cancer Research. 77(13). 3672–3684. 107 indexed citations

12.

Larrea, Esther, José Ignacio Riezu‐Boj, Rafael Aldabe, et al.. (2013). Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes. Gut. 63(4). 665–673. 20 indexed citations

13.

Garza, Rocío García de la, Pablo Sarobe, Juana Merino, et al.. (2013). Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance. Liver Transplantation. 19(9). 937–944. 70 indexed citations

14.

Aranda, Fernando, Diana Llópiz, Nancy Díaz‐Valdés, et al.. (2011). Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors. Cancer Research. 71(9). 3214–3224. 63 indexed citations

15.

Díaz‐Valdés, Nancy, Javier Dotor, Fernando Aranda, et al.. (2010). Induction of Monocyte Chemoattractant Protein-1 and Interleukin-10 by TGFβ1 in Melanoma Enhances Tumor Infiltration and Immunosuppression. Cancer Research. 71(3). 812–821. 55 indexed citations

16.

Pardo–Saganta, Ana, María U. Latasa, Josefa Castillo, et al.. (2009). The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression. Journal of Hepatology. 51(6). 1010–1020. 17 indexed citations

17.

Huarte, Eduardo, Juan R. Cubillos‐Ruiz, Yolanda C. Nesbeth, et al.. (2008). Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity. Cancer Research. 68(18). 7684–7691. 96 indexed citations

18.

Gil‐Guerrero, Lucía, Javier Dotor, Inge L. Huibregtse, et al.. (2008). In Vitro and In Vivo Down-Regulation of Regulatory T Cell Activity with a Peptide Inhibitor of TGF-β1. The Journal of Immunology. 181(1). 126–135. 57 indexed citations

19.

Lasarte, Juan José, Noëlia Casares, Marta Gorraiz, et al.. (2007). The Extra Domain A from Fibronectin Targets Antigens to TLR4-Expressing Cells and Induces Cytotoxic T Cell Responses In Vivo. The Journal of Immunology. 178(2). 748–756. 85 indexed citations

20.

Okazaki, Takahiro, C D Pendleton, Pablo Sarobe, et al.. (2006). Epitope Enhancement of a CD4 HIV Epitope toward the Development of the Next Generation HIV Vaccine. The Journal of Immunology. 176(6). 3753–3759. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact